Skip to main content
Top
Published in: Respiratory Research 1/2006

Open Access 01-12-2006 | Research

EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts

Authors: Ying Ji Li, Arata Azuma, Jiro Usuki, Shinji Abe, Kuniko Matsuda, Toshiaki Sunazuka, Takako Shimizu, Yukiyo Hirata, Hirofumi Inagaki, Tomoyuki Kawada, Satoru Takahashi, Shoji Kudoh, Satoshi Omura

Published in: Respiratory Research | Issue 1/2006

Login to get access

Abstract

Background

Fourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung injury and fibrosis in bleomycin-challenged mice via anti-inflammatory effects. EM703 is a new derivative of erythromycin (EM) without the bactericidal effects. We investigated the anti-inflammatory and antifibrotic effects of EM703 in an experimental model of bleomycin-induced lung injury and subsequent fibrosis in mice.

Methods

Seven-week-old male ICR mice were used. All experiments used eight mice/group, unless otherwise noted in the figure legends. Bleomycin was administered intravenously to the mice on day 0. EM703 was orally administered daily to mice. All groups were examined for cell populations in the bronchoalveolar lavage (BAL) fluid and for induction of messenger RNA (mRNA) of Smad3 and Smad4 in the lung tissues by reverse transcriptase (RT)-polymerase chainreaction (PCR) on day 7. Fibroblastic foci were assessed histologically, and the hydroxyproline content was chemically determined in the lung tissues on day 28. We performed assay of proliferation and soluble collagen production, and examined the induction of mRNA of Smad3 and Smad4 by RT-PCR in murine lung fibroblast cell line MLg2908. We also examined Smad3, Smad4 and phosphorylated Smad2/3 (p-Smad2/3) protein assay by western blotting in MLg2908.

Results

Bleomycin-induced lung fibrosis, and the infiltration of macrophages and neutrophils into the airspace were inhibited by EM703. The expression of Smad3 and Smad4 mRNA was clearly attenuated by bleomycin, but was recovered by EM703. EM703 also inhibited fibroblast proliferation and the collagen production in lung fibroblasts induced by Transforming growth factor-beta (TGF-β). The expression of Smad3 and Smad4 mRNA in murine lung fibroblasts disappeared due to TGF-β, but was recovered by EM703. EM703 inhibited the expression of p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-β.

Conclusion

These findings suggest that EM703 improves bleomycin-induced pulmonary fibrosis in mice by actions of anti-inflammation and regulation of TGF-β signaling in lung fibroblasts.
Literature
1.
3.
go back to reference Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M: Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998, 157:1829–1832.CrossRefPubMed Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M: Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998, 157:1829–1832.CrossRefPubMed
4.
go back to reference Jaffe A, Francis J, Rosenthal M, Bush A: Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998, 351:420.CrossRefPubMed Jaffe A, Francis J, Rosenthal M, Bush A: Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998, 351:420.CrossRefPubMed
5.
go back to reference Azuma A, Furuta T, Enomoto T, Hashimoto Y, Uematsu K, Nukariya N, Murata A, Kudoh S: Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. Thorax 1998, 53:186–189.CrossRefPubMedPubMedCentral Azuma A, Furuta T, Enomoto T, Hashimoto Y, Uematsu K, Nukariya N, Murata A, Kudoh S: Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. Thorax 1998, 53:186–189.CrossRefPubMedPubMedCentral
6.
go back to reference Li Y, Azuma A, Takahashi S, Usuki J, Kuniko M, Aoyama A, Kudoh S: Fourteen-Membered Ring Macrolides Inhibit Vascular Cell Adhesion Molecule 1 Messenger RNA Induction and Leukocyte Migration Role in Preventing Lung Injury and Fibrosis in Bleomycin-Challenged Mice. CHEST 2002, 122:2137–2145.CrossRefPubMed Li Y, Azuma A, Takahashi S, Usuki J, Kuniko M, Aoyama A, Kudoh S: Fourteen-Membered Ring Macrolides Inhibit Vascular Cell Adhesion Molecule 1 Messenger RNA Induction and Leukocyte Migration Role in Preventing Lung Injury and Fibrosis in Bleomycin-Challenged Mice. CHEST 2002, 122:2137–2145.CrossRefPubMed
7.
go back to reference DuBois RM: Interferon gamma-1β for the treatment of Idiopathic pulmonary fibrosis. N Eng J Med 1999, 341:1302–1304.CrossRef DuBois RM: Interferon gamma-1β for the treatment of Idiopathic pulmonary fibrosis. N Eng J Med 1999, 341:1302–1304.CrossRef
8.
go back to reference Ward PA, Hunninghake GW: Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998, 157:123–129.CrossRef Ward PA, Hunninghake GW: Lung inflammation and fibrosis. Am J Respir Crit Care Med 1998, 157:123–129.CrossRef
9.
10.
go back to reference Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG: Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981, 68:259–269.CrossRefPubMedPubMedCentral Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG: Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981, 68:259–269.CrossRefPubMedPubMedCentral
11.
go back to reference Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG: Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977, 59:165–175.CrossRefPubMedPubMedCentral Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG: Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977, 59:165–175.CrossRefPubMedPubMedCentral
12.
go back to reference Katzenstein AL, Askin FB: Idiopathic interstitial pneumonia/Idiopathic pulmonary fibrosis. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. Edited by: Katzenstein AL. WB: Philadelphia, Saunders; 1990:55. Katzenstein AL, Askin FB: Idiopathic interstitial pneumonia/Idiopathic pulmonary fibrosis. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease. Edited by: Katzenstein AL. WB: Philadelphia, Saunders; 1990:55.
13.
go back to reference Selman M, Pardo A: The epithelial/fibroblast pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S93-S97.PubMed Selman M, Pardo A: The epithelial/fibroblast pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S93-S97.PubMed
14.
go back to reference Pardo A, Selman M: Idiopathic pulmonary fibrosis: New insights in its pathogenesis. Int J Biochem Cell Biol 2002, 34:1534–1538.CrossRefPubMed Pardo A, Selman M: Idiopathic pulmonary fibrosis: New insights in its pathogenesis. Int J Biochem Cell Biol 2002, 34:1534–1538.CrossRefPubMed
15.
go back to reference Broekelmann TJ, Limper AH, Colby TV, McDonald JA: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991, 88:6642–6646.CrossRefPubMedPubMedCentral Broekelmann TJ, Limper AH, Colby TV, McDonald JA: Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991, 88:6642–6646.CrossRefPubMedPubMedCentral
16.
go back to reference Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C: Transforming growth factor-β 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:431–435.CrossRefPubMed Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C: Transforming growth factor-β 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:431–435.CrossRefPubMed
17.
go back to reference Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991, 5:155–162.CrossRefPubMed Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH: Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991, 5:155–162.CrossRefPubMed
18.
go back to reference Khalil N, Bereznay O, Sporn M, Greenberg AH: Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989, 170:727–37.CrossRefPubMed Khalil N, Bereznay O, Sporn M, Greenberg AH: Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989, 170:727–37.CrossRefPubMed
19.
go back to reference Raghow R, Irish P, Kang AH: Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest 1989, 84:1836–42.CrossRefPubMedPubMedCentral Raghow R, Irish P, Kang AH: Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J Clin Invest 1989, 84:1836–42.CrossRefPubMedPubMedCentral
20.
go back to reference Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A: Altered expression of small proteoglycans, collagen and transforming growth facter-β 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92:632–637.CrossRefPubMedPubMedCentral Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A: Altered expression of small proteoglycans, collagen and transforming growth facter-β 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92:632–637.CrossRefPubMedPubMedCentral
21.
go back to reference Santana A, Saxena B, Noble NA, Gold LI, Marshall BC: Increased expression of transforming growth factor β isoforms (β 1 , β 2 , β 3 ) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 1995, 13:34–44.CrossRefPubMed Santana A, Saxena B, Noble NA, Gold LI, Marshall BC: Increased expression of transforming growth factor β isoforms (β 1 , β 2 , β 3 ) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 1995, 13:34–44.CrossRefPubMed
22.
go back to reference Zhang K, Flanders KC, Phan SH: Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J pathol 1995, 147:352–361.PubMedPubMedCentral Zhang K, Flanders KC, Phan SH: Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J pathol 1995, 147:352–361.PubMedPubMedCentral
23.
go back to reference Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors -β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressedduring bleomycin-induced lung fibrosis. Am J Pathol 1997, 150:981–991.PubMedPubMedCentral Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors -β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressedduring bleomycin-induced lung fibrosis. Am J Pathol 1997, 150:981–991.PubMedPubMedCentral
24.
go back to reference Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I, Lazaridis K, Abraham DJ, Black CM, de Crombrugghe B: Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGF β) receptor leads to paradoxical activation of TGF β signaling pathways with fibrosis in transgenic mice. J Biol Chem 2003, 278:25109–25119.CrossRefPubMed Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I, Lazaridis K, Abraham DJ, Black CM, de Crombrugghe B: Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGF β) receptor leads to paradoxical activation of TGF β signaling pathways with fibrosis in transgenic mice. J Biol Chem 2003, 278:25109–25119.CrossRefPubMed
25.
go back to reference Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J: Adenovector-mediated Gene Transfer of Active Transforming Growth Factor-β1 Induces Prolonged Severe Fibrosis in Rat Lung. J Clin Invest 1997, 100:768–776.CrossRefPubMedPubMedCentral Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J: Adenovector-mediated Gene Transfer of Active Transforming Growth Factor-β1 Induces Prolonged Severe Fibrosis in Rat Lung. J Clin Invest 1997, 100:768–776.CrossRefPubMedPubMedCentral
26.
go back to reference Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD protein. Nature 1997, 390:465–471.CrossRefPubMed Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD protein. Nature 1997, 390:465–471.CrossRefPubMed
27.
go back to reference Nonaka M, Pawankar R, Tomiyama S, Yagi T: A macrolide antibiotic roxithromycin inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999, 13:267–272.CrossRefPubMed Nonaka M, Pawankar R, Tomiyama S, Yagi T: A macrolide antibiotic roxithromycin inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999, 13:267–272.CrossRefPubMed
28.
go back to reference Adams IYR, Bowden DH: The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974, 77:185–198. Adams IYR, Bowden DH: The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 1974, 77:185–198.
29.
go back to reference Aso Y, Yoneda K, Kikkawa Y: Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 1976, 35:558–568.PubMed Aso Y, Yoneda K, Kikkawa Y: Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 1976, 35:558–568.PubMed
30.
go back to reference Weidner WJ, Quam DA, McClure DE, DeFouw DO: Effect of acute administration of bleomycin on lung fluid balance in sheep. Exp Lung Res 1995, 21:617–630.CrossRefPubMed Weidner WJ, Quam DA, McClure DE, DeFouw DO: Effect of acute administration of bleomycin on lung fluid balance in sheep. Exp Lung Res 1995, 21:617–630.CrossRefPubMed
31.
go back to reference Kiminari Yoshida , Toshiaki Sunazuka , Kenichiro Nagai , Akihiro Sugawara , Achim Cho , Tohru Nagamitsu , Yoshihiro Harigaya , Kazuhiko Otoguro , Kiyoko AkagawaS, Satoshi Omura : Macrolides with promotive activity of monocyte to macrophage differentiation. J Antibiot (Tokyo) 2005,58(1):79–81.CrossRef Kiminari Yoshida , Toshiaki Sunazuka , Kenichiro Nagai , Akihiro Sugawara , Achim Cho , Tohru Nagamitsu , Yoshihiro Harigaya , Kazuhiko Otoguro , Kiyoko AkagawaS, Satoshi Omura : Macrolides with promotive activity of monocyte to macrophage differentiation. J Antibiot (Tokyo) 2005,58(1):79–81.CrossRef
32.
go back to reference Desaki M., Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H: Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother 2004, 48:1581–1585.CrossRefPubMedPubMedCentral Desaki M., Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H: Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother 2004, 48:1581–1585.CrossRefPubMedPubMedCentral
33.
34.
go back to reference Woessner JF JR: The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961, 93:440–447.CrossRef Woessner JF JR: The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961, 93:440–447.CrossRef
35.
go back to reference Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996, 97:1597–1604.CrossRefPubMedPubMedCentral Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S: Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996, 97:1597–1604.CrossRefPubMedPubMedCentral
36.
go back to reference Satoh M, Sugino H, Yoshida T: Activin promotes astrocytic differentiation of a multipotent neural stem cell line and an astrocyte progenitor cell line from murine central nervous system. Neurosci Lett 2000, 284:143–146.CrossRefPubMed Satoh M, Sugino H, Yoshida T: Activin promotes astrocytic differentiation of a multipotent neural stem cell line and an astrocyte progenitor cell line from murine central nervous system. Neurosci Lett 2000, 284:143–146.CrossRefPubMed
37.
go back to reference Boehm T, Spillantini MG, Sofroniew MV, Surani MA, Rabbitts TH: Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. Oncogene 1991, 6:695–703.PubMed Boehm T, Spillantini MG, Sofroniew MV, Surani MA, Rabbitts TH: Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. Oncogene 1991, 6:695–703.PubMed
38.
go back to reference Manos P, Nakayama R, Holten D: Regulation of glucose-6-phosphate dehydrogenase synthesis and mRNA abundance in cultured rat hepatocytes. Biochem J 1991, 276:245–250.CrossRefPubMedPubMedCentral Manos P, Nakayama R, Holten D: Regulation of glucose-6-phosphate dehydrogenase synthesis and mRNA abundance in cultured rat hepatocytes. Biochem J 1991, 276:245–250.CrossRefPubMedPubMedCentral
39.
go back to reference Azuma A, Li YJ, Abe S, Usuki J, Matsuda K, Henmi S, Miyauchi Y, Ueda k, Izawa A, Sone S, Hashimoto S, Kudho S: Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin. Am J Respir Cell Mol Biol 2005, 32:93–98.CrossRefPubMed Azuma A, Li YJ, Abe S, Usuki J, Matsuda K, Henmi S, Miyauchi Y, Ueda k, Izawa A, Sone S, Hashimoto S, Kudho S: Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin. Am J Respir Cell Mol Biol 2005, 32:93–98.CrossRefPubMed
40.
go back to reference Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P: TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16:5353–5362.CrossRefPubMedPubMedCentral Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P: TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16:5353–5362.CrossRefPubMedPubMedCentral
41.
go back to reference Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, Frederick JP, Wang XF, Warburton D: Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:L585-L593.CrossRefPubMed Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, Frederick JP, Wang XF, Warburton D: Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:L585-L593.CrossRefPubMed
42.
go back to reference Roberts AB, Piek E, Bottinger EP, Ashcroft G, Mitchell JB, Flanders KC: Is Smad3 a major player in signal transduction pathways leading to fibrogenesis ? Chest 2001, 120:43S-47S.CrossRefPubMed Roberts AB, Piek E, Bottinger EP, Ashcroft G, Mitchell JB, Flanders KC: Is Smad3 a major player in signal transduction pathways leading to fibrogenesis ? Chest 2001, 120:43S-47S.CrossRefPubMed
43.
go back to reference Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004, 173:2099–2108.CrossRefPubMed Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004, 173:2099–2108.CrossRefPubMed
44.
go back to reference Zhao Y, Geverd DA: Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-β singnaling. Biochem Biophys Res Commun 2002, 294:319–323.CrossRefPubMed Zhao Y, Geverd DA: Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-β singnaling. Biochem Biophys Res Commun 2002, 294:319–323.CrossRefPubMed
45.
go back to reference Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P: Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993, 75:681–692.CrossRefPubMed Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P: Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993, 75:681–692.CrossRefPubMed
46.
go back to reference Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775–785.CrossRefPubMed Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775–785.CrossRefPubMed
47.
go back to reference Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL: Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes. Cell 1993, 75:671–680.CrossRefPubMed Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL: Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes. Cell 1993, 75:671–680.CrossRefPubMed
48.
go back to reference Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB: Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004, 114:1308–1316.CrossRefPubMedPubMedCentral Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB: Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004, 114:1308–1316.CrossRefPubMedPubMedCentral
49.
go back to reference Dhainaut JF, Charpentier J, Chiche JD: Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003, 31:S258-S264.CrossRefPubMed Dhainaut JF, Charpentier J, Chiche JD: Transforming growth factor-β: A mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003, 31:S258-S264.CrossRefPubMed
50.
go back to reference Maeda A, Ishioka S, Taooka Y, Hiyama K, Yamakido M: Expression of transforming growth factor-β1 and tumour necrosis factor-α in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin. Respirology 1999, 4:359–363.CrossRefPubMed Maeda A, Ishioka S, Taooka Y, Hiyama K, Yamakido M: Expression of transforming growth factor-β1 and tumour necrosis factor-α in bronchoalveolar lavage cells in murine pulmonary fibrosis after intraperitoneal administration of bleomycin. Respirology 1999, 4:359–363.CrossRefPubMed
51.
go back to reference Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell-associated latent TGF-β secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996, 15:252–259.CrossRefPubMed Khalil N, Corne S, Whitman C, Yacyshyn H: Plasmin regulates the activation of cell-associated latent TGF-β secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996, 15:252–259.CrossRefPubMed
52.
go back to reference Sakamaki A, Ishizaka A., Urano T, Sayama k, Nakamura H, Terashima T, Waki Y, Tasaka S, Hasegawa N, Sato K, Nakagawa N, Obata T, Kanazawa M: Effect of specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1996, 153:391–397.CrossRefPubMed Sakamaki A, Ishizaka A., Urano T, Sayama k, Nakamura H, Terashima T, Waki Y, Tasaka S, Hasegawa N, Sato K, Nakagawa N, Obata T, Kanazawa M: Effect of specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1996, 153:391–397.CrossRefPubMed
54.
go back to reference Iyer SN, Gurujeyalakshmi G, Giri SN: Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999,289(1):211–218.PubMed Iyer SN, Gurujeyalakshmi G, Giri SN: Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999,289(1):211–218.PubMed
55.
go back to reference Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH: A preliminary study of long-term treatment with interferon gamma-1β and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999,341(17):1264–1269.CrossRefPubMed Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH: A preliminary study of long-term treatment with interferon gamma-1β and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999,341(17):1264–1269.CrossRefPubMed
Metadata
Title
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
Authors
Ying Ji Li
Arata Azuma
Jiro Usuki
Shinji Abe
Kuniko Matsuda
Toshiaki Sunazuka
Takako Shimizu
Yukiyo Hirata
Hirofumi Inagaki
Tomoyuki Kawada
Satoru Takahashi
Shoji Kudoh
Satoshi Omura
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2006
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-7-16

Other articles of this Issue 1/2006

Respiratory Research 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.